Perez EA, Dang C, Lee C, Singh J, et al. Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review. Breast Cancer Res Treat 2022 May 19. pii: 10.1007/s10549-021-06469.
PMID: 35587323